PMID- 33801988 OWN - NLM STAT- MEDLINE DCOM- 20210426 LR - 20221207 IS - 1660-4601 (Electronic) IS - 1661-7827 (Print) IS - 1660-4601 (Linking) VI - 18 IP - 6 DP - 2021 Mar 10 TI - Is 25-Hydroxyvitamin D Associated with Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia? A Population Based Study. LID - 10.3390/ijerph18062805 [doi] LID - 2805 AB - BACKGROUND: Saudi Arabia has a high burden of diabetes mellitus and vitamin D deficiency. The objective of this study was to explore the association between glycosylated hemoglobin and 25-hydroxyvitamin D in patients with type 2 diabetes mellitus (T2DM) in Riyadh, Saudi Arabia. METHODS: An interview based cross-sectional study was conducted on 606 patients with type 2 diabetes, aged 30-75 years, visiting primary health care centers. Blood samples were collected for measuring HbA1c, 25(OH)D and bone and lipid markers. Multivariable linear regression analysis was conducted to explore the association between HbA1c and 25(OH)D. RESULTS: The mean (+/-SD) levels for HbA1c and 25(OH) D were 7.69 (+/-1.77) and 44.28 (+/-23.06), respectively. Around 55% of patients had uncontrolled HbA1c (>7.0), whereas vitamin D deficiency (<50 nmol/L) was found in 52.3% (=317). Multiple linear regression analysis found that a unit increase in vitamin D levels and parathyroid hormone levels was associated with -0.17 (-0.02, -0.01, p < 0.001) and -0.20 (-2.66, -1.18, p < 0.001) unit decrease in levels of HbA1c, respectively. Similarly, increasing age was associated with -0.15 (-0.01, -0.04, p = 0.002) unit decrease in HbA1c levels, whereas unit increases in serum alkaline phosphatase, calcium and diabetes duration were associated with 0.22 (0.01, 0.02, p < 0.001), 0.14 (1.03, 3.88, p = 0.001) and 0.26 (0.42, 0.78, p < 0.001) unit increase in HbA1c levels, respectively. CONCLUSION: HbA1c levels are associated with 25-hydroxyvitamin D levels. For better control of HbA1c levels, it is important to maintain 25-hydroxyvitamin D level and bone markers within normal range. FAU - AlQuaiz, AlJohara M AU - AlQuaiz AM AD - Reserach Chairs Program, Princess Nora Bent Abdullah Chair for Women's Health Research, King Saud University, Riyadh 231831, Saudi Arabia. AD - Department of Family & Community Medicine, College of Medicine, King Saud University, Riyadh 7065, Saudi Arabia. FAU - Alrasheed, Abdullah A AU - Alrasheed AA AD - Department of Family & Community Medicine, College of Medicine, King Saud University, Riyadh 7065, Saudi Arabia. FAU - Kazi, Ambreen AU - Kazi A AUID- ORCID: 0000-0002-6807-8555 AD - Reserach Chairs Program, Princess Nora Bent Abdullah Chair for Women's Health Research, King Saud University, Riyadh 231831, Saudi Arabia. AD - Department of Family & Community Medicine, College of Medicine, King Saud University, Riyadh 7065, Saudi Arabia. FAU - Batais, Mohammad Ali AU - Batais MA AD - Department of Family & Community Medicine, College of Medicine, King Saud University, Riyadh 7065, Saudi Arabia. FAU - Alhabeeb, Khaled M AU - Alhabeeb KM AUID- ORCID: 0000-0002-7421-8788 AD - Reserach Chairs Program, Princess Nora Bent Abdullah Chair for Women's Health Research, King Saud University, Riyadh 231831, Saudi Arabia. FAU - Jamal, Amr AU - Jamal A AUID- ORCID: 0000-0002-4051-6592 AD - Department of Family & Community Medicine, College of Medicine, King Saud University, Riyadh 7065, Saudi Arabia. FAU - Fouda, Mona A AU - Fouda MA AD - Reserach Chairs Program, Princess Nora Bent Abdullah Chair for Women's Health Research, King Saud University, Riyadh 231831, Saudi Arabia. AD - Endocrinology Division, Department of Medicine, College of Medicine, King Saud University, Riyadh 7065, Saudi Arabia. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210310 PL - Switzerland TA - Int J Environ Res Public Health JT - International journal of environmental research and public health JID - 101238455 RN - 0 (Glycated Hemoglobin A) RN - 1406-16-2 (Vitamin D) RN - A288AR3C9H (25-hydroxyvitamin D) SB - IM MH - Adult MH - Aged MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2/epidemiology MH - Glycated Hemoglobin/analysis MH - Humans MH - Middle Aged MH - Saudi Arabia/epidemiology MH - Vitamin D/analogs & derivatives MH - *Vitamin D Deficiency/epidemiology PMC - PMC7999091 OTO - NOTNLM OT - 25-hydroxyvitamin D OT - HbA1c OT - Saudi Arabia OT - Type 2 diabetes mellitus COIS- The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. EDAT- 2021/04/04 06:00 MHDA- 2021/04/27 06:00 PMCR- 2021/03/10 CRDT- 2021/04/03 01:10 PHST- 2021/01/20 00:00 [received] PHST- 2021/03/03 00:00 [revised] PHST- 2021/03/05 00:00 [accepted] PHST- 2021/04/03 01:10 [entrez] PHST- 2021/04/04 06:00 [pubmed] PHST- 2021/04/27 06:00 [medline] PHST- 2021/03/10 00:00 [pmc-release] AID - ijerph18062805 [pii] AID - ijerph-18-02805 [pii] AID - 10.3390/ijerph18062805 [doi] PST - epublish SO - Int J Environ Res Public Health. 2021 Mar 10;18(6):2805. doi: 10.3390/ijerph18062805.